Aortic Valve

Article

Maternal, Valvular and Foetal Outcomes of Pregnancy Following Aortic Valve Replacement 

May 13, 2026 | Erica CurcioBronze Contributor

This 2026 meta-analysis pooled 13 studies, including 356 pregnancies in 251 women after aortic valve replacement (AVR). Pregnancy outcomes differed substantially by valve type. Mechanical prostheses carried the highest maternal risk, with maternal death and...

Article

Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes After Surgical Aortic Valve Replacement

May 7, 2026 | Erica CurcioBronze Contributor

In this article, the authors evaluated perioperative sodium-glucose cotransporter 2 (SGLT2) inhibitor use in 2,930 patients undergoing surgical aortic valve replacement (SAVR), with or without coronary artery bypass grafting (CABG),...

Article

Association Between Surgical Timing and Postoperative Outcomes in Type A Acute Aortic Dissection

May 7, 2026 | Erica CurcioBronze Contributor

This retrospective cohort study aimed to evaluate the association between symptom-to-admission time and postoperative outcomes following Type A acute aortic dissection (TAAD) repair. Analyzing 1,228 patients treated within 72 hours...

Article

Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis at 10 Years

May 7, 2026 | Erica CurcioBronze Contributor

In this article, the authors present the 10-year follow–up of the RECOVERY trial involving 145 asymptomatic patients with very severe aortic stenosis, comparing early surgical aortic valve replacement with conservative...

Article

Mechanical Versus Biological Aortic Valve Replacement in Patients Aged 50-70 Years: A Systematic Review and Meta-Analysis

April 2, 2026 | Jason Trevis

This systematic review and meta-analysis evaluated outcomes after aortic valve replacement in patients aged 50 to 70 years, including 30 studies and more than 120,000 patients. The findings indicated that...

Article

‘Concerning’ Trends Seen in Aortic Stenosis-Related Mortality: CDC WONDER

March 26, 2026 | Joel DunningGold ContributorSilver Commentor

A study using the CDC WONDER database revealed concerning tending in aortic stenosis-related mortality, showing an increase in deaths among adults aged 45 to 74 years since the expansion of...

Article

Bioprosthetic Versus Mechanical Surgical Aortic Valve Replacement in Patients ≥65 Years of Age

March 19, 2026 | Mujtaba Mubashir

This retrospective study evaluated the longitudinal outcomes of bioprosthetic (bAVR) versus mechanical surgical aortic valve replacement (mAVR) in Medicare beneficiaries aged 65 years old and older (n=69,423). After risk adjustment,...

Article

Mid-Term Valve Performance and Durability of the Ozaki Procedure in Patients on Chronic Dialysis

March 19, 2026 | Mujtaba Mubashir

This retrospective study evaluated the hemodynamics and durability of the Ozaki procedure in chronic dialysis patients compared to two groups: non-dialysis Ozaki patients and dialysis patients receiving bioprosthetic aortic valve...

Article

Updated 5-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low- to Intermediate-Surgical Risk

March 5, 2026 | Joel DunningGold ContributorSilver Commentor

This study conducted a systematic review and meta-analysis of randomized controlled trials comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) in low- to intermediate- surgical risk...

Article

Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

February 26, 2026 | Vincent Sier

In this article, the authors report six-year outcomes from the Evolut Low Risk trial, which randomized 1,414 low-risk patients with severe aortic stenosis to transcatheter aortic valve replacement (TAVR) (n=730)...

Article

Postdilation of Evolut Transcatheter Heart Valves: Insights From Bench Testing

February 26, 2026 | Vincent Sier

In this brief report, the authors present an ex vivo bench study evaluating the impact of post-dilation strategies on Evolut FX+ transcatheter heart valves (23, 26, 29, and 34 mm)....

Article

Balloon- Versus Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses: 3-Year Results of the LYTEN Trial

February 19, 2026 | Vincent Sier

In this article, the authors present the three-year results of the randomized LYTEN trial comparing balloon-expandable valves (BEV; SAPIEN 3/ULTRA) and self-expanding valves (SEV; Evolut R/PRO/PRO+) for valve-in-valve transcatheter aortic...

Article

Transcatheter Aortic Valve-in-Mechanical Valve Replacement: A First-in-Human Study 

February 19, 2026 | Vincent Sier

In this article, the authors present a bench-to-animal-to-human proof of concept for valve-in-mechanical (ViMech) transcatheter aortic valve implantation (TAVI) in patients with failed bileaflet mechanical aortic valves. Bench testing showed...

LOAD MORE